Author： Shahda Safi Saif Muhammad Wasif
Publisher： Informa Healthcare
ISSN： 1751-2433
Source： Expert Review of Clinical Pharmacology, Vol.6, Iss.3, 2013-05, pp. : 243-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. :
Access to resources
Recommend
Vascular NO: from bench to bedside
European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. :
CETUXIMAB: From Bench to Bedside
Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. :
Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)
Current Cancer Drug Targets, Vol. 15, Iss. 8, 2015-01 ,pp. :
Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. :